A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 Diabetes
Status:
Completed
Trial end date:
2021-01-04
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effect of the study drug tirzepatide to insulin
degludec on blood sugar levels in participants with type 2 diabetes. The study will last
about 67 weeks and may include up to 22 visits.